Trial
NCT00534209
Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Miami
Collaborators
—
Condition
Lung Cancer
Intervention
Allogeneic B7.1/HLA-A1
Why stopped
Per request of Principal Investigator this study was closed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-16